Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michalis Kontos

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JAMA Surgery|September 25, 2024
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast CancerIda Skarping, Pär-Ola Bendahl, Robert Szulkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2024
Quality assessment of radiotherapy in the prospective randomized SENOMAC trialSara Alkner, Elinore Wieslander, Dan Lundstedt, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Breast Cancer Research and Treatment|March 6, 2023
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologistsCarl Sars, Helena Sackey, Jan Frisell, et al.
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trialRosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, et al.
The Lancet. Oncology|August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer GroupsDavid Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2025
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
The British Journal of Surgery|September 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort studyThorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JAMA Surgery|September 25, 2024
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast CancerIda Skarping, Pär-Ola Bendahl, Robert Szulkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2024
Quality assessment of radiotherapy in the prospective randomized SENOMAC trialSara Alkner, Elinore Wieslander, Dan Lundstedt, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Breast Cancer Research and Treatment|March 6, 2023
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologistsCarl Sars, Helena Sackey, Jan Frisell, et al.
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trialRosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, et al.
The Lancet. Oncology|August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer GroupsDavid Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2025
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
The British Journal of Surgery|September 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort studyThorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, et al.
Pageof 4